Showing results (381-390 of 595) with videos related to
Sort By:
Pageof 60
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 12, 2025
Noninfectious Uveitis in Pediatric Rheumatology: Long-term Follow-up at Tertiary CentersNergis Akay, Umit Gul, Oya Koker, et al.American Heart Journal|May 28, 2013
Developing an ST-elevation myocardial infarction system of care in Dallas CountyJami DelliFraine, James Langabeer, Wendy Segrest, et al.JAMA|January 9, 2019
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialTracy Y Wang, Lisa A Kaltenbach, Christopher P Cannon, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2019
Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trialTarun Chakravarty, Timothy D Henry, Michelle Kittleson, et al.Prehospital and Disaster Medicine|May 21, 2020
The Effect of Implementation of the American Heart Association Mission Lifeline PreAct Algorithm for Prehospital Cardiac Catheterization Laboratory Activation on the Rate of "False Positive" ActivationsJuliana Tolles, Nichole Bosson, Amy H Kaji, et al.Circulation. Cardiovascular Quality and Outcomes|May 24, 2012
Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: LifelineJames G Jollis, Christopher B Granger, Timothy D Henry, et al.American Heart Journal|July 5, 2021
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerationsThomas J Povsic, Timothy D Henry, E Magnus Ohman, et al.Circulation. Heart Failure|January 19, 2021
Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit PatientsJacob C Jentzer, Barry Burstein, Sean Van Diepen, et al.Plos One|August 26, 2020
Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trialsXiaoyin Wang, Lourdes I Chacon, Ronak Derakhshandeh, et al.Journal of the American Heart Association|April 18, 2020
Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance ProgramsJacob A Doll, Lisa A Kaltenbach, Kevin J Anstrom, et al.Pageof 60